New York, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Polymerase Chain Reaction Industry" - https://www.reportlinker.com/p05957722/?utm_source=GNW
Instruments, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Consumables segment is readjusted to a revised 5% CAGR for the next 7-year period.
The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 7.7% CAGR
The Polymerase Chain Reaction market in the U.S. is estimated at US$2.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2027 trailing a CAGR of 7.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.We bring years of research experience to this 9th edition of our report. The 279-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- Abbott Molecular, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- QIAGEN NV
- Siemens Healthcare GmbH
- Thermo Fisher Scientific, Inc.
Read the full report: https://www.reportlinker.com/p05957722/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Polymerase Chain Reaction Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Polymerase Chain
Reaction by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027
Table 2: World Historic Review for Polymerase Chain Reaction by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 3: World 15-Year Perspective for Polymerase Chain
Reaction by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2020 & 2027
Table 4: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027
Table 5: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019
Table 6: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Reagents &
Consumables by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027
Table 8: World Historic Review for Reagents & Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 9: World 15-Year Perspective for Reagents & Consumables
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Academic &
Research Institutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027
Table 11: World Historic Review for Academic & Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 12: World 15-Year Perspective for Academic & Research
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027
Table 13: World Current & Future Analysis for Clinical
Diagnostic Labs & Hospitals by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027
Table 14: World Historic Review for Clinical Diagnostic Labs &
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 15: World 15-Year Perspective for Clinical Diagnostic
Labs & Hospitals by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
Table 16: World Current & Future Analysis for Pharmaceutical &
Biotechnology Sector by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027
Table 17: World Historic Review for Pharmaceutical &
Biotechnology Sector by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019
Table 18: World 15-Year Perspective for Pharmaceutical &
Biotechnology Sector by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
Table 19: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027
Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 21: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Polymerase Chain Reaction Market Share (in %) by Company:
2019 & 2025
Market Analytics
Table 22: USA Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 23: USA Historic Review for Polymerase Chain Reaction by
Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 24: USA 15-Year Perspective for Polymerase Chain Reaction
by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 25: USA Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 26: USA Historic Review for Polymerase Chain Reaction by
End-Use - Academic & Research Institutes, Clinical Diagnostic
Labs & Hospitals, Pharmaceutical & Biotechnology Sector and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019
Table 27: USA 15-Year Perspective for Polymerase Chain Reaction
by End-Use - Percentage Breakdown of Value Sales for Academic &
Research Institutes, Clinical Diagnostic Labs & Hospitals,
Pharmaceutical & Biotechnology Sector and Other End-Uses for
the Years 2012, 2020 & 2027
CANADA
Table 28: Canada Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 29: Canada Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 30: Canada 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 31: Canada Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 32: Canada Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 33: Canada 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
JAPAN
Table 34: Japan Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 35: Japan Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 36: Japan 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 37: Japan Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 38: Japan Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 39: Japan 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
CHINA
Table 40: China Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 41: China Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 42: China 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 43: China Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 44: China Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 45: China 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
EUROPE
Market Facts & Figures
European Polymerase Chain Reaction Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 46: Europe Current & Future Analysis for Polymerase Chain
Reaction by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027
Table 47: Europe Historic Review for Polymerase Chain Reaction
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 48: Europe 15-Year Perspective for Polymerase Chain
Reaction by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2020 & 2027
Table 49: Europe Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 50: Europe Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 51: Europe 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 52: Europe Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 53: Europe Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 54: Europe 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
FRANCE
Table 55: France Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 56: France Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 57: France 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 58: France Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 59: France Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 60: France 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
GERMANY
Table 61: Germany Current & Future Analysis for Polymerase
Chain Reaction by Segment - Instruments and Reagents &
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 62: Germany Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 63: Germany 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 64: Germany Current & Future Analysis for Polymerase
Chain Reaction by End-Use - Academic & Research Institutes,
Clinical Diagnostic Labs & Hospitals, Pharmaceutical &
Biotechnology Sector and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
Table 65: Germany Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 66: Germany 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
ITALY
Table 67: Italy Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 68: Italy Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 69: Italy 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 70: Italy Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 71: Italy Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 72: Italy 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 73: UK Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 74: UK Historic Review for Polymerase Chain Reaction by
Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 75: UK 15-Year Perspective for Polymerase Chain Reaction
by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 76: UK Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 77: UK Historic Review for Polymerase Chain Reaction by
End-Use - Academic & Research Institutes, Clinical Diagnostic
Labs & Hospitals, Pharmaceutical & Biotechnology Sector and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019
Table 78: UK 15-Year Perspective for Polymerase Chain Reaction
by End-Use - Percentage Breakdown of Value Sales for Academic &
Research Institutes, Clinical Diagnostic Labs & Hospitals,
Pharmaceutical & Biotechnology Sector and Other End-Uses for
the Years 2012, 2020 & 2027
SPAIN
Table 79: Spain Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 80: Spain Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 81: Spain 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 82: Spain Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 83: Spain Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 84: Spain 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
RUSSIA
Table 85: Russia Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 86: Russia Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 87: Russia 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 88: Russia Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 89: Russia Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 90: Russia 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
REST OF EUROPE
Table 91: Rest of Europe Current & Future Analysis for
Polymerase Chain Reaction by Segment - Instruments and Reagents &
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 92: Rest of Europe Historic Review for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 93: Rest of Europe 15-Year Perspective for Polymerase
Chain Reaction by Segment - Percentage Breakdown of Value Sales
for Instruments and Reagents & Consumables for the Years 2012,
2020 & 2027
Table 94: Rest of Europe Current & Future Analysis for
Polymerase Chain Reaction by End-Use - Academic & Research
Institutes, Clinical Diagnostic Labs & Hospitals,
Pharmaceutical & Biotechnology Sector and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 95: Rest of Europe Historic Review for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 96: Rest of Europe 15-Year Perspective for Polymerase
Chain Reaction by End-Use - Percentage Breakdown of Value Sales
for Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Table 97: Asia-Pacific Current & Future Analysis for Polymerase
Chain Reaction by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027
Table 98: Asia-Pacific Historic Review for Polymerase Chain
Reaction by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 99: Asia-Pacific 15-Year Perspective for Polymerase Chain
Reaction by Geographic Region - Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027
Table 100: Asia-Pacific Current & Future Analysis for
Polymerase Chain Reaction by Segment - Instruments and Reagents &
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 101: Asia-Pacific Historic Review for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 102: Asia-Pacific 15-Year Perspective for Polymerase
Chain Reaction by Segment - Percentage Breakdown of Value Sales
for Instruments and Reagents & Consumables for the Years 2012,
2020 & 2027
Table 103: Asia-Pacific Current & Future Analysis for
Polymerase Chain Reaction by End-Use - Academic & Research
Institutes, Clinical Diagnostic Labs & Hospitals,
Pharmaceutical & Biotechnology Sector and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 104: Asia-Pacific Historic Review for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 105: Asia-Pacific 15-Year Perspective for Polymerase
Chain Reaction by End-Use - Percentage Breakdown of Value Sales
for Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
AUSTRALIA
Table 106: Australia Current & Future Analysis for Polymerase
Chain Reaction by Segment - Instruments and Reagents &
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 107: Australia Historic Review for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 108: Australia 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 109: Australia Current & Future Analysis for Polymerase
Chain Reaction by End-Use - Academic & Research Institutes,
Clinical Diagnostic Labs & Hospitals, Pharmaceutical &
Biotechnology Sector and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
Table 110: Australia Historic Review for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 111: Australia 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
INDIA
Table 112: India Current & Future Analysis for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027
Table 113: India Historic Review for Polymerase Chain Reaction
by Segment - Instruments and Reagents & Consumables Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019
Table 114: India 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 115: India Current & Future Analysis for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027
Table 116: India Historic Review for Polymerase Chain Reaction
by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 117: India 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
SOUTH KOREA
Table 118: South Korea Current & Future Analysis for Polymerase
Chain Reaction by Segment - Instruments and Reagents &
Consumables - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027
Table 119: South Korea Historic Review for Polymerase Chain
Reaction by Segment - Instruments and Reagents & Consumables
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019
Table 120: South Korea 15-Year Perspective for Polymerase Chain
Reaction by Segment - Percentage Breakdown of Value Sales for
Instruments and Reagents & Consumables for the Years 2012, 2020 &
2027
Table 121: South Korea Current & Future Analysis for Polymerase
Chain Reaction by End-Use - Academic & Research Institutes,
Clinical Diagnostic Labs & Hospitals, Pharmaceutical &
Biotechnology Sector and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
Table 122: South Korea Historic Review for Polymerase Chain
Reaction by End-Use - Academic & Research Institutes, Clinical
Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology
Sector and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019
Table 123: South Korea 15-Year Perspective for Polymerase Chain
Reaction by End-Use - Percentage Breakdown of Value Sales for
Academic & Research Institutes, Clinical Diagnostic Labs &
Hospitals, Pharmaceutical & Biotechnology Sector and Other
End-Uses for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05957722/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________